Scientific update: obesity care goes beyond BMI

Published: 29 August 2026 7 min read Dr. Shimaa Fouad

Medically reviewed by: Dr. Alyaa Said Abu Taleb

This article was translated into English from the Arabic original and reviewed for medical accuracy.

Article illustration: Scientific update: obesity care goes beyond BMI

Why BMI on its own is not enough

Body mass index (BMI) is calculated from weight and height, which makes it a quick and inexpensive way to screen populations. The World Health Organization describes obesity as a chronic, complex disease and uses BMI as the practical adult definition [9]. The limitation is that the number does not distinguish fat from muscle, bone or water, and it does not show where fat is stored in the body [2, 4].

Two people with exactly the same BMI can therefore be in very different health situations. One may carry a lot of muscle with normal blood pressure and glucose; the other may carry fat around the abdomen with raised glucose, fatty liver or breathing problems during sleep. The 2025 Lancet Commission on clinical obesity stated plainly that BMI is a surrogate for body fat and should be confirmed with another measure, such as waist circumference or waist-to-height ratio, or with direct fat measurement where available [4].

This does not make BMI useless. It is a helpful starting point and still enters decisions such as when to discuss medicine or surgery. The real scientific update is that the number opens the conversation rather than closing it, and a treatment decision needs a much wider picture [1, 5].

Waist size and fat distribution add important information

Current NICE guidance (NG246) recommends measuring waist-to-height ratio alongside BMI in adults with a BMI below 35. The simple message is to keep your waist to less than half your height. A ratio from 0.5 to below 0.6 indicates increased health risk from central fat, and 0.6 or more indicates high risk [2].

The same guidance notes that people from some family backgrounds, including Middle Eastern, South Asian and African backgrounds, develop metabolic risk at a lower BMI, so lower classification thresholds are used for them [2]. That matters in Egypt, because a number that looks acceptable on a generic chart may hide real risk. An international consensus statement also described waist circumference as a vital sign that should be measured routinely, because at the same BMI a larger waist is linked with higher cardiometabolic risk [7].

Measurement technique matters: take it on skin or light clothing, at the same point each time, at the end of a normal breath out. The details of visceral fat and device readings are covered in the article on visceral fat, waist and InBody, which explains why the number needs to be read alongside examination and blood tests rather than on its own [7].

Clinical and preclinical obesity: what is the difference?

The Lancet Commission proposed a new division between two situations. Preclinical obesity means excess fat with organ function and daily activity still preserved, but with a higher risk of future disease. Clinical obesity is an established chronic illness in which excess fat is already affecting the function of one or more organs, or limiting daily activities such as moving, bathing and dressing [4].

The Commission set out specific adult criteria, including breathlessness, signs of heart failure, raised glucose or blood pressure, fatty liver with fibrosis, and knee or hip pain and stiffness caused by weight [4]. The point is that diagnosis rests on health and function, not on appearance or a number alone.

Years earlier, the Edmonton Obesity Staging System (EOSS) offered a related idea, staging the condition from zero to four according to related diseases, mental health and functional ability. A study of a large population cohort found that this stage predicted mortality better than BMI [6]. In practice, someone with preclinical obesity may need monitoring, prevention and risk reduction, while someone with clinical obesity needs active treatment of the disease and its complications [4, 6].

What a full assessment includes

The Canadian adult obesity guideline suggests that assessment should look for the causes and factors that maintain weight gain, for complications, and for barriers that may get in the way of treatment [5]. That includes weight history since childhood, previous attempts and why they stopped, sleep, stress and mood, eating patterns and episodes of overeating, and medicines that can increase weight, such as some antidepressants, steroids or diabetes treatments [5, 10].

Examination may include blood pressure and waist, with a check of joints and breathing. Blood tests are chosen by the clinician according to the situation, such as HbA1c or fasting glucose, lipids, liver tests, and thyroid function where symptoms point that way [2, 5]. The NHS reminds readers that obesity is linked with type 2 diabetes, heart disease, some cancers and effects on mental health as well [10].

If this is your first time at a weight clinic, the guide to a first weight-management visit explains the questions and measurements step by step. What matters is that assessment ends with a list of priorities: the most important health problem now, what can improve quickly, and what needs time [5].

Respect and language are part of treatment

An international consensus statement endorsed by dozens of scientific societies in 2020 stated that weight stigma harms health, and that assuming obesity is simply the result of laziness or lack of willpower is inconsistent with the evidence [8]. Stigma leads many people to delay seeing a doctor, avoid tests, or feel too ashamed to mention important symptoms. It can also lead clinicians to attribute every symptom to weight and miss another diagnosis [8].

This is why EASO and NICE emphasise respectful, person-first language and asking permission before discussing weight [1, 3]. You are entitled to ask why a measurement is needed and what it will change in the plan. You can also say if stepping on the scale causes distress and agree on an approach that works for you.

At the same time, respect does not mean ignoring complications. Good care states the medical facts clearly without blame, and sets realistic health goals such as better glucose, blood pressure, sleep or walking ability, rather than a particular appearance or an ideal number [5, 8].

Treatment options follow the whole picture

The Canadian guideline describes treatment as a foundation of nutrition, physical activity and psychological and behavioural support, with medicine or surgery added when needed [5]. The US Preventive Services Task Force (USPSTF) recommends that adults with a BMI of 30 or more be offered or referred to intensive, multicomponent behavioural programmes, because they improve weight and some risk factors [13].

Medicines have a defined place. NIDDK explains that they are usually discussed when BMI is 30 or more, or 27 or more with a weight-related health problem, and that they work alongside changes in eating and activity rather than replacing them [12]. NICE sets out when medicines or obesity surgery should be discussed, taking account of lower thresholds for some ethnic backgrounds [14]. If you are considering medicine, read why weight medicines are not a short course to understand why continuity and follow-up are part of the plan.

During any weight loss, protecting muscle matters, particularly with newer medicines or very low intakes. The article on protecting muscle while losing weight explains the role of protein and resistance exercise. In the end the decision is shared: benefits, harms and alternatives are discussed openly, and your choice is a central part of it [11, 12].

How to measure progress beyond the scale

If diagnosis is based on health and function, progress should be measured the same way. Useful markers can include waist circumference, blood pressure, HbA1c, liver enzymes, sleep quality, joint pain, and the ability to walk or climb stairs [4, 5]. Weight loss itself matters, and guidelines note that relatively modest loss can improve many risk factors, but the number is not the only measure [11].

Some people see their weight pause for a while as their waist or glucose improves, and that is real progress worth recording. Others lose weight quickly but lose muscle or feel unwell, which calls for a review of the plan rather than simple celebration [5]. Regular follow-up allows the plan to be adjusted instead of the person being blamed when a step does not work.

If you need an individual assessment that brings measurements, blood tests and nutrition into one plan, you can book an appointment at the clinic. This is a practical next step rather than a promised result, and the treating team will decide which measurements and steps suit your situation [1, 5].

Knowledge Centre

How this article was reviewed

This content is for health education and does not replace diagnosis or an individual care plan.

Author listed in record
Dr. Shimaa Fouad
Reviewer listed in record
Dr. Alyaa Said Abu Taleb
Linked medical sources
14
Publication and review history
  1. Published: 29 August 2026
  2. Last updated: 27 September 2026
  3. 27 September 2026: The update was expanded to cover the 2025 clinical obesity definition, waist-to-height ratio, full assessment, treatment and progress markers, with verified sources and FAQs, and was medically re-reviewed.
  4. Review record: A reviewer is listed in the publication record
  5. Linked medical sources: 14

Frequently asked questions

Yes, it is possible. BMI does not show fat distribution, and fat concentrated around the abdomen is linked with metabolic risk even at a BMI that looks normal. This is why NICE recommends measuring waist-to-height ratio and uses lower thresholds for people of Middle Eastern background [2, 7].

According to the 2025 Lancet Commission, it is a condition in which excess fat is already affecting the function of an organ, such as the heart, liver, joints or breathing, or limiting basic daily activities. It needs active treatment rather than prevention alone [4].

Measure your waist with a tape halfway between the lowest rib and the top of the hip bone, at the end of a normal breath out, then divide by your height in the same unit. A result of 0.5 or more is a good reason to discuss risk with a clinician [2, 7].

Not necessarily. Relatively modest weight loss can improve blood pressure, glucose and other risk factors in many people. What matters is setting the goal around your health problem and measuring it with markers such as waist, blood tests, sleep and movement, not only the scale [5, 11].

Yes. Guidelines encourage asking permission before discussing weight and using respectful language. You can agree with your clinician when a measurement is genuinely useful and when it can wait, as long as it does not affect an important medical decision [1, 3, 8].

No. An assessment may lead to a nutrition and activity plan, follow-up, treatment of a related condition, or a discussion of medicine or surgery if suitable. Medicine is decided according to BMI, health status, benefits, harms and your choice [12, 14].

Written by

Dr. Shimaa Fouad

Dr. Shimaa Fouad

Physician, Clinical & Therapeutic Nutrition Specialist, ESPEN member

  • Physician; specialist in clinical and therapeutic nutrition and weight management
  • Member of the European Society for Clinical Nutrition and Metabolism (ESPEN)
  • Over 18 years of experience
  • Focus on insulin resistance, PCOS, hypothyroidism and metabolic disorders
  • Obesity alongside rheumatological and immune conditions; healthy weight gain

Dr. Shimaa Fouad is a physician specialising in clinical and therapeutic nutrition and weight management, and a member of the European Society for Clinical Nutrition and Metabolism (ESPEN), with more than 18 years of experience. She focuses on cases where standard diets have not worked, such as insulin resistance, polycystic ovary syndrome, hypothyroidism and metabolic disorders, and obesity alongside rheumatic and immune conditions, as well as underweight and healthy weight gain. Each plan is built on a full InBody analysis and a reading of the medical tests rather than a ready-made diet, with weekly follow-up and adjustments as progress is made.

View profile

You may also find helpful

Article illustration: Mounjaro results timeline: what to expect
Medical articles Weight Management
Published: 1 October 2026 10 min read

Mounjaro results timeline: what to expect

When might tirzepatide affect appetite and weight, and how should progress at 4, 12 and 20 weeks be read? A realistic guide to trial averages and individual results.

Learn more

Start with a real consultation - book now

Booking ahead is required. Patients are seen in order of arrival.